Carol Lynn Brosgart - 06 Apr 2020 Form 4 Insider Report for Enochian Biosciences Inc (RENB)

Role
Director
Signature
Carol Lynn Brosgart
Issuer symbol
RENB
Transactions as of
06 Apr 2020
Net transactions value
$0
Form type
4
Filing time
21 Dec 2021, 10:50:25 UTC
Next filing
08 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RENB Option to purchase shares of common stock Award $0 +25,424 $0.000000 25,424 28 Dec 2020 Common stock 25,424 $2.95 Direct F1
transaction RENB Option to purchase shares of common stock Award $0 +15,625 $0.000000 15,625 06 Apr 2020 Common stock 15,625 $4.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 28, 2020, Dr. Brosgart was granted an option to purchase 25,424 shares of common stock of Enochian Biosciences Inc., said option to vest on December 28, 2021.
F2 On April 6, 2020, Dr. Brosgart was granted an option to purchase 15,625 shares of common stock of Enochian Biosciences Inc., said option to vest on December 27, 2020.